LISTEN IN: CDC, FDA talk about pausing J&J vaccine after 6 clotting cases

Representatives of the Centers for Disease Control and Prevention and the Food and Drug Administration spoke about their joint recommendation for a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

The event began shortly after 10 a.m.:

The state of Ohio and local health districts have followed the advice of the federal officials, pausing new administration of Johnson & Johnson doses or registration for upcoming J&J clinics.

ExploreLive updates from the Associated Press on J&J vaccine pause

In Other News

Dayton Arcade’s newest vendor is a boutique dry bar with high-end...

Increasing mental health counseling help in region goal of WSU...

Xenia company to boost Pentagon’s rocket motor industrial base

Elections board won’t hear Kettering council candidate’s appeal due to...

Woman indicted by grand jury in domestic dispute shooting in Dayton